Histone deacetylase inhibitors (HDACIs) are effective small molecules in the treatment of human cancers. In our continuing efforts to develop novel N-hydroxyterephthalamide-based HDACIs, herein we report the design and development of a new class of N-hydroxybenzamide-based HDACIs. In this new class of analogs, we inserted an ethylene moiety in the linker and used indole as a part of the Y-shaped cap group. Biological characterization identified compounds 4o, 4p, 4q and 4t to show improved HDAC inhibition, while no isoform selectivity for HDACs was observed. These compounds also exhibited improved anti-proliferative activity against multiple cancer cell lines when compared to their parent compound and positive control SAHA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2018.02.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrated molecular modeling and dynamics approaches revealed the mechanism of selective inhibition of HDAC6/8.
J Biomol Struct Dyn
November 2024
Beijing Key Laboratory of Environmental and Oncology, Faculty of Environment and Life, Beijing University of Technology, Beijing, China.
Article Synopsis
- * Understanding the selective inhibition mechanisms of HDAC6 and HDAC8 involves key interactions, such as hydrogen bonding with specific residues (Asp101 and Tyr306 for HDAC8, His610 for HDAC6), which influence the compound's shape and binding stability.
- * The position of the Cap group in the compound affects its selectivity for HDAC6 or HDAC8, providing crucial insights for designing selective dual-target inhibitors that could minimize side effects in therapeutic applications.
Structure-specific amyloid precipitation in biofluids.
Nat Chem
September 2022
Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
The composition of soluble toxic protein aggregates formed in vivo is currently unknown in neurodegenerative diseases, due to their ultra-low concentration in human biofluids and their high degree of heterogeneity. Here we report a method to capture amyloid-containing aggregates in human biofluids in an unbiased way, a process we name amyloid precipitation. We use a structure-specific chemical dimer, a Y-shaped, bio-inspired small molecule with two capture groups, for amyloid precipitation to increase affinity.
View Article and Find Full Text PDFStructural characterization of a new subclass of panicum mosaic virus-like 3' cap-independent translation enhancer.
Nucleic Acids Res
February 2022
Department of Cell Biology and Molecular Genetics, University of Maryland - College Park, College Park, MD 20742, USA.
Canonical eukaryotic mRNA translation requires 5'cap recognition by initiation factor 4E (eIF4E). In contrast, many positive-strand RNA virus genomes lack a 5'cap and promote translation by non-canonical mechanisms. Among plant viruses, PTEs are a major class of cap-independent translation enhancers located in/near the 3'UTR that recruit eIF4E to greatly enhance viral translation.
View Article and Find Full Text PDFEnzyme-free fluorometric assay for chloramphenicol based on double stirring bar-assisted dual signal amplification.
Mikrochim Acta
February 2019
Faculty of Material Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China.
An enzyme-free fluorometric assay is described that accomplishes dual signal amplification by making use of a two stirring bars. Two Y-shaped DNA probes were designed and placed on the bars. When the target (with chloramphenicol as model analyte) is added, it triggers target recycling and simultaneously catalyzes hairpin assembly (CHA).
View Article and Find Full Text PDFStructure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap.
Bioorg Med Chem
May 2018
Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Science, Shandong University, 44 West Wenhua Road, 250012 Ji'nan, Shandong, PR China. Electronic address:
Histone deacetylase inhibitors (HDACIs) are effective small molecules in the treatment of human cancers. In our continuing efforts to develop novel N-hydroxyterephthalamide-based HDACIs, herein we report the design and development of a new class of N-hydroxybenzamide-based HDACIs. In this new class of analogs, we inserted an ethylene moiety in the linker and used indole as a part of the Y-shaped cap group.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!